Baca berita tanpa iklan. Gabung

Indonesia Highlights: AstraZeneca Denies Using Swine Trypsin in Its Covid-19 Vaccine| Mishap at Jakarta’s Halim Airport Causes Diversion of Flights to Soekarno-Hatta Airport | Indonesian Embassy in Ja

March 21, 2021, 08.06 AM

JAKARTA, – Indonesia is set to use AstraZeneca’s Covid-19 vaccine on Monday, days after the company was hit by allegations that it used swine trypsin and was subject to a WHO review for allegedly causing blood clots and even death.

Indonesian low-cost carriers Batik Air and Citilink were forced to divert seven flights in between them from Halim Perdanukusuma to Soekarno-Hatta International Airport, after a cargo jet slipped and blocked the runway.

And the Indonesian Embassy in Tokyo is trying to account for Indonesian nationals in Japan, after the Miyagi Prefecture in northern Japan was hit by a 7.2 Richter scale earthquake that triggered a tsunami warning. This and more on Indonesia Highlights:

A drive-thru Covid-19 vaccineGrab A drive-thru Covid-19 vaccine

AstraZeneca Denies Using Swine Trypsin in Its Covid-19 Vaccine

British pharmaceutical company AstraZeneca has refuted reports that its Covid-19 vaccine contains trypsin from swine, after Indonesia authorized the use of its Covid-19 vaccine for mass vaccinations next week.

AstraZeneca made the assertion, after the Indonesian Ulama Council or MUI issued a fatwa authorizing use of the vaccine despite its alleged use of swine trypsin, due to the emergency situation brought about by the coronavirus pandemic.

“We would like to clarify that AstraZeneca’s Covid-19 vaccine is a virus vector that contains no animal products,” AstraZeneca said in its press release on Saturday.

“The British MHRA [Medicines and Healthcare products Regulatory Agency] has confirmed this. We have not used animal products at all levels of the vaccine’s development.”

The allegations that the vaccine contained swine products occurred nearly two weeks after Indonesia received its first batch of 1.1 million vaccines from AstraZeneca on March 8.

Indonesia followed suit with 17 countries, including the Netherlands and Thailand, in suspending use of the AstraZeneca vaccine pending a World Health Organization [WHO] review.

This development came following reports that the vaccine induced potentially lethal blood clots among its recipients. The Indonesian Food and Drug Agency or BPOM vouched for the vaccine.

“BPOM found that the AstraZeneca vaccine’s benefits still outweigh its risks. The European Medicine Agency [EMA] has found that the vaccine has nothing to do with the risks of blood clotting,” said BPOM’s spokesperson for the Covid-19 vaccine Lucia Rizka Andalusia.

Lucia’s Ministry of Health counterpart Siti Nadia Tarmizi also hailed BPOM and MUI’s decision to endorse the AstraZeneca vaccine. The AstraZeneca vaccine is authorized for use in Indonesia next Monday, March 22.


A twin engined jet plane similar to a Boeing 737-500KOMPAS IMAGES / RODERICK ADRIAN MOZES A twin engined jet plane similar to a Boeing 737-500


Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

April 14, 2023, 12.38 PM

Indonesia Detects New Covid Arcturus Variant

Baca berita tanpa iklan. Gabung
Baca berita tanpa iklan. Gabung


Baca berita tanpa iklan. Gabung
Baca berita tanpa iklan. Gabung
Close Ads